CSPC Pharmaceutical Group Limited (FRA:CVG)
Germany flag Germany · Delayed Price · Currency is EUR
0.7276
+0.0076 (1.06%)
At close: May 21, 2025, 10:00 PM CET

CSPC Pharmaceutical Group Statistics

Total Valuation

FRA:CVG has a market cap or net worth of EUR 10.03 billion. The enterprise value is 9.18 billion.

Market Cap 10.03B
Enterprise Value 9.18B

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date May 23, 2025
Ex-Dividend Date Oct 31, 2024

Share Statistics

Current Share Class 11.43B
Shares Outstanding n/a
Shares Change (YoY) -1.85%
Shares Change (QoQ) -1.02%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 7.82B

Valuation Ratios

The trailing PE ratio is 18.75 and the forward PE ratio is 15.90.

PE Ratio 18.75
Forward PE 15.90
PS Ratio 2.91
PB Ratio 2.32
P/TBV Ratio 2.66
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 17.17
EV / Sales 2.83
EV / EBITDA 12.56
EV / EBIT 15.94
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA 0.08
Debt / FCF n/a
Interest Coverage 109.38

Financial Efficiency

Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 8.64%.

Return on Equity (ROE) 12.21%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 8.64%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 161,109
Profits Per Employee 24,982
Employee Count 21,400
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -6.62% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -6.62%
50-Day Moving Average 0.66
200-Day Moving Average 0.62
Relative Strength Index (RSI) 72.23
Average Volume (20 Days) 2,912

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:CVG had revenue of EUR 3.45 billion and earned 534.62 million in profits. Earnings per share was 0.05.

Revenue 3.45B
Gross Profit 2.36B
Operating Income 617.93M
Pretax Income 677.85M
Net Income 534.62M
EBITDA 761.58M
EBIT 617.93M
Earnings Per Share (EPS) 0.05
Full Income Statement

Balance Sheet

The company has 1.17 billion in cash and 64.68 million in debt, giving a net cash position of 1.10 billion.

Cash & Cash Equivalents 1.17B
Total Debt 64.68M
Net Cash 1.10B
Net Cash Per Share n/a
Equity (Book Value) 4.32B
Book Value Per Share 0.36
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 68.45%, with operating and profit margins of 17.92% and 15.51%.

Gross Margin 68.45%
Operating Margin 17.92%
Pretax Margin 19.66%
Profit Margin 15.51%
EBITDA Margin 22.09%
EBIT Margin 17.92%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 4.88%.

Dividend Per Share 0.04
Dividend Yield 4.88%
Dividend Growth (YoY) 19.27%
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield 1.85%
Shareholder Yield 6.72%
Earnings Yield 5.33%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.

Last Split Date Oct 15, 2020
Split Type Forward
Split Ratio 1.6

Scores

Altman Z-Score n/a
Piotroski F-Score n/a